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We have examined the effect of the Y-flanking region of the human insulin gene on its expression in non-pancreatic cells. 
The presence of the region containing the insulin gene enhancer (- 339 to - 169 bp) markedly repressed the promoter 
activity of the insulin gene. This suppressive phenomenon was restored by the addition of forskolin or dibutyryl CAMP, 
suggesting that this region alone is not suIIicient o repress completely insulin gene expression i  the presence of extracellu- 
lar stimuli which increase the intracellular CAMP level. The hypervariable region (HVR) located at -365 bp also repres- 
sed the promoter activity. These results show negative regulation of human insulin gene expression in non-pancreatic 
cells by these regions. 
Negative regulation; Insulin gene; cyclic AMP 
1. INTRODUCTION 
The insulin gene is expressed in pancreatic B cells 
in a tissue-specific manner and activated in 
response to extracellular inducers such as glucose 
and CAMP [l-4]. The 5 ’ -flanking region of the in- 
sulin gene contains two &acting elements, the 
enhancer and the promoter, which exert their ef- 
fect on transcription by interacting with various 
trans-acting factors which restrict insulin gene ex- 
pression to the endocrine pancreas [1,5-71. 
Recently, Nir et al. [8] have shown the presence 
of a negative trans-acting factor(s) which interacts 
with the 5 ’ -flanking region of the rat insulin I gene 
in non-pancreatic cells. Stein and Ziff [9] have 
shown also that adenovirus type 5 infection to the 
insulin producing cell line, HIT T-15, repressess 
rat insulin II gene transcription. These findings 
suggest that, in addition to being regulated in a 
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positive fashion, insulin gene expression also can 
be negatively regulated. 
A unique hypervariable region (HVR) linked to 
the human insulin gene, which consists of a vary- 
ing number of 14 or 15 nucleotides in repetition, 
resides -365 bp upstream from the cap site 
[lO,l 11. This characteristic feature of the HVR is 
observed only in humans and higher apes [ 121. The 
heterogeneity of the HVR in length has been exten- 
sively studied as a possible genetic marker of 
susceptibility to diabetes mellitus [ 131. However, 
the functional role of the HVR and its surrounding 
sequences in the regulation of human insulin gene 
expression is unknown. Since the sequence of the 
enhancer and its upstream region of the insulin 
gene in rats and humans is relatively divergent, 
compared to the promoter region [4], it seems 
possible that insulin gene expression by these 
regions is regulated differently in the two species. 
Here, we have examined the effect of the human 
insulin gene enhancer and its upstream regions in- 
cluding the HVR on insulin gene expression in 
non-pancreatic cells, CV-1 and HeLa cells. We 
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have also studied the effect of CAMP on insulin 
gene expression in these cells. 
2. MATERIALS AND METHODS 
2.1. Plasmid construction 
The structures of a series of recombinant CAT plasmids used 
are schematically shown in fig.1. The BglII-PstI fragment 
(- 168 to + 111 bp from the cap site) containing the promoter 
region of the human insulin gene was inserted into the Hind111 
site of pSVOCAT [14] using a Hind111 linker, designated 
pHICAT. The PstI fragment (- 339 to + 111 bp) containing 
both the human insulin promoter and the enhancer egions was 
inserted into the Hind111 site of pSVOCAT to generate 
pHICAT-4. The HVR adjacent o the human insulin gene can 
be classified into three groups according to variation in length: 
class l-3 [15]. Class 1 (700 bp) and class 3 (2 kb) fragments 
were prepared by NcoI and PstI digestion and were placed adja- 
cent to the insulin promoter region of the pHICAT using an 
XhoI linker, designated pHICAT- and pHICAT-3, respective- 
ly. The constructs with fragments of class 1 and 3 in opposite 
directions were also prepared, denoted as pHICAT-lr and 
pHICAT-3r, respectively. 
2.2. Cell cultures and DNA transfection 
The human epitheloid carcinoma cell line, HeLa, and the 
African green monkey kidney cell line, CV-1, were maintained 
in ES medium (Nissui Seiyaku, Japan) supplemented with 10% 
fetal bovine serum. Cells were plated at a density of 4 x 10s per 
A 
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3.1. Negative regulation of insulin gene expression 
by the enhancer-containing region in non- 
pancreatic cells 
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The plasmid containing the human insulin gene 
promoter region (pHICAT) produced relatively 
high levels of CAT activity in both CV-1 and HeLa 
cells (fig.2). In contrast, the plasmid pHICAT- in 
which the enhancer region of the human insulin 
gene was placed adjacent to the promoter region 
decreased CAT activity to about 10 and 20% of 
that obtained by pHICAT in CV-1 and HeLa cells, 
respectively, suggesting that insulin gene expres- 
sion is negatively regulated by the region from 
- 339 to - 169 bp in these cells. Fig. 1. (A) Schematic representation of the 5 ‘-flanking region of 
the human insulin gene. (B) Various CAT plasmid 
constructions. The hatched box represents a CAT gene. The 
closed and open boxes indicate the promoter region and the 
HVR, respectively. H, HindIII; X, XhoI. 
10 cm Nunc tissue culture plate. A mixture of 18 pg of each 
plasmid DNA and 2 pg of pRSV-j3-gal plasmid DNA was 
transfected using the calcium-phosphate precipitation method 
[la]. The plasmid pRSV-&gal, which carries the&galactosidase 
gene linked to the Rous sarcoma virus LTR promoter, provided 
an internal control for measuring differences in transfection ef- 
ficiency among the experiments [17]. Forskolin (10 ,uM), 
dibutyryl CAMP (0.1 mM), phorbol 1Zmyristate 13-acetate 
(PMA) (0.1 mM), or glucose at various concentrations (50, 100 
or 200 mg/dl) were added to the medium 20 h after 
transfection. 
2.3. &Galactosidase and CA T assays 
40 h after transfection, the cells were harvested in 150,41 of 
0.25 M Tris-HCl (PH 7.8) and lysed by freeze-thawing and 
sonication to prepare extracts. For the ,&galactosidase assay, 
6021 samples were incubated at 37°C for 1 h with 500~1 
chlorophenol red-,%D-galactopyranoside solution (30.37 mg/ 
ml in 2.5 mM MgClz) and the absorbance at 574 run was 
measured. The amounts of cell extract used for CAT assays 
were normalized with respect o @-galactosidase activity. CAT 
enzyme reactions were performed as described by Gorman et al. 
[14] using 0.7 &i [‘4C]chloramphenicol. Acetylated reaction 
products were separated by thin-layer chromatography. Fol- 
lowing autoradiography, the acetylated and unreacted forms 
were excised and counted in a scintillation counter. 
2.4. Preparation of nuclear extract and gel retardation assay 
A nuclear protein extract was prepared from HeLa cells as 
described by Wu [18]. The gel retardation assay was performed 
as described by Singh et al. [ 191. The XhoI class 1 fragment was 
prepared from pHICAT- (fig.lB) and 32P labeled at the 
5 ‘-end. After preincubation with poly(dI-dC) : poly(dI-dC), 
HeLa nuclear extracts were incubated with the 5’-end-labeled 
class 1 fragment. The reaction products were separated by 4% 
polyacrylamide gel electrophoresis under low ionic conditions. 
Insulin gene expression is modulated by glucose 
in pancreatic ,8 cells partly via CAMP-dependent 
protein kinase [3]. We have investigated, 
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Fig.2. Effect of the 5’-flanking region of the human insulin 
gene on CAT gene expression. CV-1 (A) and HeLa (B) cells 
were transfected with a reporter plasmid, and then treated with 
PMA, forskolin, or dibutyryl CAMP. AC, acetylated 
derivatives of chloramphenicol; CM, unreacted species. CAT 
activities are shown on the right as a relative ratio to that of 
pHICAT. 
therefore, whether the suppressive effect of the 
enhancer region can be modulated in response to 
an increased CAMP level in non-pancreatic ells. In 
fact, there is a motif in the 5 ‘-flanking region of 
the human insulin gene similar to the CAMP 
responsive element (CRE), 5 ’ -TGACGACCA-3 ’ 
( - 181 to - 174 bp), which is highly conserved in 
many other genes whose expression is regulated by 
CAMP [20]. The plasmid pHICAT- containing 
the insulin promoter and enhancer regions was 
transfected into CV-1 cells and the medium was 
subsequently treated with dibutyryl CAMP or for- 
skolin to increase the intracellular CAMP level. 
The suppression of CAT activity by the plasmid 
pHICAT- was found to be restored to the level of 
that obtained by pHICAT in response to both in- 
ducers (fig.2A). However, when HeLa cells were 
transfected with the same plasmid, there was little 
noticeable increase in CAT activity in response to 
these reagents, as compared with CV-1 cells 
(fig.2B). It is therefore likely that the CRE func- 
tions with a certain cell specificity. We also in- 
vestigated the effect of two other insulin 
secretagogues, glucose and PMA [21,22]. No in- 
crease in CAT activity by these inducers was 
observed in HeLa nor CV-1 cells (figs 2,3). To ex- 
clude the possibility that increased glucose was not 
taken up by the cells, Northern blot analysis was 
performed using the Hep G2-type glucose 
transporter cDNA probe [23]. An accumulation of 
glucose transporter mRNA proportional to the ex- 
tracellular glucose concentrations in CV-1 cells 
showed that the glucose signal had been introduced 
into the cells (fig.3). 
3.2. Negative regulation of insulin gene expression 
by HVR 
The unique HVR class 1 (700 bp) or class 3 
(2 kb) fragment was placed adjacent to the pro- 
moter region of the insulin gene to study its effect 
on insulin gene expression. Regardless of the orien- 
tation or length variation of the HVR, the level of 
CAT activity was reduced to about 20% of that 
obtained by the promoter region alone (fig.4), in- 
glucose 50 100 200 50 100 200 (maIdI) 
Fig.3. Effect of glucose concentration on CAT gene expression. 
CV-1 cells were transfected with pHICAT- and treated with 
various concentrations of glucose. On the right are shown 
2.9 kb mRNA species which hybridized to the HepGZ-type 
glucose transporter cDNA probe (231. 15 cg total RNA were 
applied in each lane. Northern blot analysis was performed as 
in [24]. 
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Fig.4. Effect of the HVR on CAT gene expression. CV-1 (A) 
and HeLa (B) cells were transfected with a reporter plasmid 
harboring class 1 or 3 fragments. CAT activities are expressed 
as a relative ratio to that of pHICAT. 
dicating that the HVR has a suppressive ffect on 
insulin gene expression in nonpancreatic cells. 
Treatment of cells with glucose, PMA, or 
dibutyryl CAMP failed to elevate CAT activity (not 
shown). The latter two inducers had been expected 
to modulate the effect of the HVR, since the HVR 
contains a consensus sequence, 5 ’ -TCCC- 
CAGGCC3 ’ [ 111, for the AP-2 binding site in the 
anti-sense strand, recently characterized as a final 
transmitter operating through a complex pathway 
of the effects of phorbol ester and/or CAMP [20]. 
Thus, the suppressive ffect of the HVR on the 
transcription was not affected by these ex- 
tracellular modulators, which suggests a 
mechanism different from that of the enhancer 
region. 
Furthermore, gel retardation assay reveals a 
band corresponding to the DNA-protein complex 
44 
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Fig.5. Gel retardation assay using a 5’-end labeled class 1 
fragment and a crude nuclear extract from HeLa cells. The 
band corresponding to the DNA-protein complex is shown. To 
prevent nonspecific binding, poly(dI * dC) was used as a carrier. 
(fig.5), suggesting the presence of a possible truns- 
acting protein(s) bound to the HVR in HeLa cells, 
although whether this factor is responsible for the 
suppressive function of the HVR is unknown at 
present. 
4. DISCUSSION 
The 5 ‘-flanking region of the rat insulin 1 gene, 
from - 219 to + 51 bp from the transcription start 
site, has recently been suggested to be responsible 
for the negative regulation of gene transcription 
[8]. However, a mutational analysis by Karlsson et 
al. [7] failed to detect any key component sequence 
that would contribute to the negative control. This 
raises the possibility that multiple DNA regions are 
involved in repression of insulin gene transcription 
and also that a deletion of only one region does not 
interfere with the negative regulation. Further- 
more, the previous finding that the sequence of the 
enhancer egion and its upstream region of the in- 
sulin gene is relatively divergent between rats and 
humans [4] suggests that the negative regulation of 
insulin gene expression may differ between the two 
species. 
We have demonstrated here that the region con- 
taining the human insulin gene enhancer also 
possesses a suppressive ffect on transcription in 
non-pancreatic ells, as does the 5 ’ -flanking region 
of the rat insulin I gene. Our results also show that 
an increase in intracellular CAMP level blocks the 
suppressive ffect of the enhancer egion on insulin 
gene expression in CV-1 cells, suggesting that this 
region alone is not sufficient to repress completely 
Volume 247, number 1 FEBS LETTERS April 1989 
insulin gene expression in response to various 
stimuli in non-pancreatic cells. It is likely, 
therefore, that the positive regulation of insulin 
gene expression by CAMP is exerted by the putative 
CRE, 5’-TGACGCCA-3’ (- 181 to -174 bp), 
similar to the consensus equence observed in other 
genes in which transcription is regulated by CAMP 
P01. 
Extracellular glucose is the major physiological 
regulator of insulin biosynthesis in pancreatic p 
cells [21]; its effect is mediated in part by CAMP- 
dependent protein kinase. Unlike CAMP 
analogues, however, the addition of glucose’failed 
to stimulate the activity of the human insulin pro- 
moter which is linked to the CRE region, sug- 
gesting that the signal-transduction pathway of 
glucose is not linked to the CAMP pathway in CV-1 
cells. In pancreatic ,& cells, phorbol ester has also 
been shown to be a strong insulin secretagogue 
which activates the Ca2+-phospholipid-dependent 
protein kinase [22]. Recently, the CRE of the 
human VIP gene was demonstrated to mediate 
transcriptional regulation by phorbol ester and 
CAMP in HeLa cells (Fink, I.S. et al., The En- 
docrine Society, 70th Annual Meeting, 1988). 
However, in the present study, PMA failed to in- 
duce CAT expression in CV-1 or HeLa cells, sug- 
gesting that there is no link between the phorbol 
ester and the CAMP pathway in insulin gene ex- 
pression in non-pancreatic ells. 
In this study, we have also shown that the HVR 
has a suppressive ffect on insulin gene expression 
in non-pancreatic ells. The study of Walker et al. 
[l] using deletion analysis has indicated that the 
HVR does not influence gene expression in rodent 
insulin-producing cells. The discrepancy between 
the two experiments might be explained by the cell- 
specific difference in regulating insulin gene ex- 
pression. An alternative explanation is that a trans- 
acting factor(s) which interacts with the HVR of 
humans is lacking in rodent cells. Although the 
HVR contains the consensus sequence for AP-2 
binding [20] which mediates transcriptional activa- 
tion in response to CAMP and/or phorbol ester, 
the suppressive ffect of the HVR on insulin gene 
expression was not affected by dibutyryl CAMP 
nor PMA. It appears, therefore, that the negative 
regulation of insulin gene expression by the HVR 
is not modulated by the ATP-2 binding element; 
alternatively, the sequence, 5’-TCCCCAGGCC-3’ 
present on the anti-sense strand of the HVR may 
be incomplete for the AP-2 binding site. 
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